methyl 3-allyl-2-imino-2,3-dihydrobenzo[d]thiazole-6-carboxylate hydrobromide, 95.0%, 500mg

1,3,5-TRIPHENYLISOCYANURATE, 97.0%, 250mg

Oxazole, 2,2'-cyclohexylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-,(4S,4'S)-, 97%, 100mg

2-methyl-3'-morpholinomethyl benzophenone, 97.0%, 1g

5-chloro-3-(2-methoxyethyl)-1,2,4-thiadiazole, 95.0%, 1g

6-((BENZYLOXY)CARBONYL)-2-(TERT-BUTOXYCARBONYL)-2,6-DIAZASPIRO[3.4]OCTANE-8-CARBOXYLIC ACID, 95.0%, 100mg

Perfluorophenyl 1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oate, 95%, 250mg

2-Bromo-1-phenylpropane, 95.0%, 1g

Cooling box -20 °C for 32 reaction vials (4 x 8), 1 Piece

2-Amino-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide, 97.0%, 10g

2-Amino-N-(4-methoxybenzyl)benzamide, 100mg

2-methylbenzene-1,3,5-triol, 1g

(5-(METHOXYMETHYL)OXAZOL-4-YL)METHANAMINE HCL, 95%, 250mg